More on CRVS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-50.0% Growth)
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (8/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Corvus Pharma (NQ:CRVS)
Delayed: 12.92 -0.15 (1.15%)
Prev. Close $13.07  
Open$13.17 
52 Wk High$17.77 
52 Wk Low$9.63 
Day High$13.51 
Day Low$12.91 
P/E N/A  
EPS$0.00 
Volume844,589 

Friends, Peers and Foes (?): GILD, REGN, 1ZLB, DNA, EXEL (more...)

Jul 27, 2026 04:28 PM Form SCHEDULE 13G/A Corvus Pharmaceuticals, Filed by: BlackRock, Inc.
Jul 22, 2026 04:02 PM Form 8-K Corvus Pharmaceuticals, For: Jul 21
Jun 15, 2026 05:12 PM Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: Moore David Scott
Jun 15, 2026 05:10 PM Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: CLARK IAN T
Jun 15, 2026 05:08 PM Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: Grais Linda
Jun 15, 2026 05:07 PM Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: Thompson Peter A.
Jun 15, 2026 05:04 PM Form 4 Corvus Pharmaceuticals, For: Jun 11 Filed by: van den Broek Richard
Jun 12, 2026 04:01 PM Form 8-K Corvus Pharmaceuticals, For: Jun 11
Jun 9, 2026 07:30 AM Corvus Pharmaceuticals invests $5 million in Angel Pharmaceuticals
Jun 9, 2026 07:30 AM Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China
View All Articles

Entities mentioned with CRVS

View All Entities